Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Meiragtx Holdings Plc (MGTX)

Meiragtx Holdings Plc (MGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Icosavax, Inc. (ICVX) Reports Q1 Loss, Lags Revenue Estimates Zacks - Wed May 10, 2023

Icosavax, Inc. (ICVX) delivered earnings and revenue surprises of 0% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ICVX : 15.31 (-0.91%)
MGTX : 5.71 (+0.53%)
Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Lags Revenue Estimates Zacks - Tue May 9, 2023

Xenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of -1.61% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

XENE : 39.80 (-1.34%)
MGTX : 5.71 (+0.53%)
Certara, Inc. (CERT) Matches Q1 Earnings Estimates Zacks - Mon May 8, 2023

Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 1.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CERT : 16.08 (-2.37%)
MGTX : 5.71 (+0.53%)
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Misses Revenue Estimates Zacks - Thu Nov 10, 2022

MeiraGTx Holdings PLC (MGTX) delivered earnings and revenue surprises of -66% and 66.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

MGTX : 5.71 (+0.53%)
INVO : 0.9850 (-1.50%)
MeiraGTx Reports Second Quarter 2022 Financial and Operational Results Globe Newswire - Thu Aug 11, 2022

-- Recent Positive Topline Data from the Phase 1/2 Trial of Botaretigene Sparoparvovec (AAV-RPGR) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)...

MGTX : 5.71 (+0.53%)
Epizyme (EPZM) Reports Q2 Loss, Tops Revenue Estimates Zacks - Tue Aug 9, 2022

Epizyme (EPZM) delivered earnings and revenue surprises of 41.67% and 172.20%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

EPZM : 1.4700 (-1.34%)
MGTX : 5.71 (+0.53%)
Vanda Pharmaceuticals (VNDA) Q2 Earnings and Revenues Miss Estimates Zacks - Wed Aug 3, 2022

Vanda (VNDA) delivered earnings and revenue surprises of -54.55% and 3.90%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

VNDA : 5.48 (-1.79%)
MGTX : 5.71 (+0.53%)
MeiraGTx Announces Financing Agreement with Perceptive Advisors for Up to $100 Million Secured by Manufacturing Facilities Globe Newswire - Wed Aug 3, 2022

- Credit facility is collateralized by MeiraGTx’s wholly-owned manufacturing facilities in London, UK and Shannon, Ireland - $75 million at closing...

MGTX : 5.71 (+0.53%)
MeiraGTx Announces Positive Top-Line Data from the MGT009 Phase 1/2 Clinical Study Demonstrating Safety and Improvement in Multiple Domains of Vision in X-Linked Retinitis Pigmentosa Patients treated with Botaretigene Sparoparvovec (AAV-RPGR) compared to Globe Newswire - Tue Jun 28, 2022

• The primary outcome of the MGT009 study is safety, and botaretigene sparoparvovec treatment was found to be generally safe and well-tolerated ...

MGTX : 5.71 (+0.53%)
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates Zacks - Thu May 12, 2022

MeiraGTx Holdings PLC (MGTX) delivered earnings and revenue surprises of -42.86% and 39.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

MGTX : 5.71 (+0.53%)
ANGN : 10.0000 (+2.04%)

Barchart Exclusives

3 Airline Stocks That Analysts Like Better Than Southwest Barchart - Fri May 17, 1:51PM CDT
With Southwest Airlines shares taking a major blow amid Boeing’s ongoing safety concerns, here are three airline stocks that analysts favor. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot